Alexandre Heraud

Alexandre has broad experience in Healthcare Venture Capital. Since 2012, Alexandre specialized in the innovation sector, in USA at the French Chamber of Commerce of San Diego, then at Wilco. His position as investment director for Venture Capital funds specializing in healthcare at Xerys and now Anaxago, allowed him to build solid knowledge in Biotech …

Dr Thomas Joudinaud, MD

Thomas has broad experience in healthcare ranging from practicing medicine to research, development and commercialization of therapeutics. He is a Cardio-vascular Thoracic surgeon by training and have more than 10 years of strategy consulting experience specialized in healthcare. Today, Thomas is CEO of Ceres-Brain Therapeutics, a biotech company spin-off from the CEA, and specialized in …

Dr Christian Pradeyrol, MD

Dr PRADEYROL is the Executive Chairman and Founder of Pradeyrol Développement, a family office actively investing in new technologies. With participations in a dozen of Biotech companies in France and in the US, Pradeyrol Développement is highly interested in immunology and preventive medicines, in vaccines, drugs and diagnostics. Prior experience: • Chairman and CEO, IMAXIO …

Frédéric Schynts, PhD

Frédéric is a scientist with Virology, Immunology and Vaccinology background, experienced in vaccine, cell and gene therapy development from R&D to clinical phase, Business Development and Company Development strategy. Continuous learning and training on the Managerial and Entrepreneurial aspect of the Biotech Industry. Prior experience: • Investment Manager, Noshaq (2020-Present) • Independent Consultant (Schynts Consulting, …

Dr Michael Watson, MD

Michael Watson has a high-level expertise in the structure and drivers of global health and national policy. He started his career as an internal physician at the NHS, before joining the biopharmaceutical industry and holds a track record of executive leadership positions for several vaccine technology manufacturers. Overall, Mike brings over 20 years of leadership …

Alexandre Le Vert

Alexandre has more than 20 years of experience in healthcare ranging from research and development to commercialization of vaccines and therapeutics He is an experienced entrepreneur in biotech and innovation Alexandre is a Board Member of several biotech companies in France and in the US Prior experience: • CEO, IMAXIO (2011-2017) • Investment Director, Pradeyrol …